サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1547526

医師調剤コスメシューティカルの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global Physician Dispensed Cosmeceuticals Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日
ページ情報
英文 128 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
医師調剤コスメシューティカルの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年07月01日
発行: Value Market Research
ページ情報: 英文 128 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医師調剤コスメシューティカル市場の世界需要は、2023年の113億3,000万米ドルから2032年には233億3,000万米ドル近くの市場規模に達し、調査期間2024～2032年のCAGRは8.35%になると推定されます。

医師調剤コスメシューティカルとは、手術やボトックスのような他の治療と併用して、あるいは併用せずに、より高い効果をもたらすよう特別に配合された、健康診断で推奨される様々な化粧品を指します。これらの製品は、調合方法や品質、強度がOTC製品とは異なります。ペプチドの濃度と供給は、線維芽細胞の活性やコラーゲンの合成を促進することで、肌の外観により大きな影響を与えます。ライセンシングを受けたスキンケアの専門家による知識豊富な指導のもと、患者の肌、状態、ライフスタイルに合わせて、より多様な使い方ができます。また、さまざまな肌タイプや要件に合うよう、さまざまな強さ、配合、濃度で提供されています。

市場力学

スキンケア需要の大幅な伸びと、皮膚、髪、爪に適した製品を推奨してくれる皮膚科医や美容医を患者が信頼し始めたことが、医師調剤コスメシューティカルの主要動向要因であろう。都市部の人々の間で、皮膚、毛髪、目へのダメージの増加を引き起こすストレスや汚染のレベルが上昇していることは、市場の成長にプラスに働くと考えられます。いくつかの病状を対象とした、より新しく先進的なコスメシューティカルの研究開発は、市場成長をさらに促進すると考えられます。皮膚科医の助言に基づき、コスメシューティカルの製造・販売を専門とする様々な化粧品新興企業が市場にプラスの影響を与えると考えられます。漢方薬という斬新な概念の出現は、オーガニックの医師調剤用コスメシューティカルの需要を押し上げると考えられます。市場リーダーによって設定された高い品質基準と厳格な政府規制は、市場にとってほとんど障害とならないです。

調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、医師調剤コスメシューティカルの世界市場における各セグメントを包括的に評価することもできます。医師調剤コスメシューティカル産業の成長と動向は、この調査に全体的なアプローチを記載しています。

市場セグメンテーション

医師調剤コスメシューティカル市場レポートのこのセクションでは、国別と地域別のセグメントに関する詳細なデータを提供し、それによって戦略担当者がそれぞれの製品またはサービスの対象層を特定する際に、今後のビジネス機会を支援します。

地域分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける医師調剤コスメシューティカル市場の現在と将来の需要を強調する地域展望をカバーします。さらに、本レポートでは、著名な全地域における個々の用途セグメントの需要、推定・予測に焦点を当てています。

ご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 医師調剤コスメシューティカル-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカー一覧
    • 主要原材料の価格動向
  • 潜在的バイヤー一覧
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 医師調剤コスメシューティカルの世界市場分析：製品タイプ別

  • 製品タイプ別概要
  • 製品タイプ別過去・予測データ分析
  • フェイスケア
  • スキンケア

第6章 医師調剤コスメシューティカルの世界市場分析：適応症別

  • 適応症別概要
  • 適応症別過去・予測データ分析
  • 皮膚の美白または色素沈着除去
  • リタイドリダクション
  • 抗シワ/老化
  • 傷跡改善
  • その他

第7章 医師調剤コスメシューティカルの世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第8章 医師調剤コスメシューティカル企業の競合情勢

  • 医師調剤コスメシューティカル市場競争
  • パートナーシップ/提携/合意
  • 合併・買収
  • 新製品発売
  • その他の開発

第9章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • AbbVie Inc.（Allergan）
  • L'Oreal S.A.
  • Jan Marini Skin Research Inc.
  • Athena Cosmetics Inc.
  • ZO Skin Health Inc.
  • Galderma Laboratories
  • L.P.
  • Procter & Gamble Co.
  • The EsteE Lauder Companies Inc.
  • Merz Pharma
  • Obagi Cosmeceuticals LLC
  • IS CLINICAL
  • Neutrogena
  • Velius LLC
  • Sonoma Pharmaceuticals Inc.
  • Sientra Inc.
  • Dynamic Techno Medicals
  • Implantech Associates Inc
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product Type (USD MN)
  • Face-care Market Sales By Geography (USD MN)
  • Skincare Market Sales By Geography (USD MN)
  • Analysis By Indication (USD MN)
  • Skin Lightening or De-pigmenting Market Sales By Geography (USD MN)
  • Rhytide Reduction Market Sales By Geography (USD MN)
  • Anti-Wrinkle/Aging Market Sales By Geography (USD MN)
  • Scar-reducing Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Physician Dispensed Cosmeceuticals Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Physician Dispensed Cosmeceuticals Report
  • Market Research Process
  • Market Research Methodology
  • Global Physician Dispensed Cosmeceuticals Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product Type
  • Market Attractiveness Analysis By Indication
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product Type (USD MN)
  • Face-care Market Sales By Geography (USD MN)
  • Skincare Market Sales By Geography (USD MN)
  • Global Market Analysis By Indication (USD MN)
  • Skin Lightening or De-pigmenting Market Sales By Geography (USD MN)
  • Rhytide Reduction Market Sales By Geography (USD MN)
  • Anti-Wrinkle/Aging Market Sales By Geography (USD MN)
  • Scar-reducing Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11215073

The global demand for Physician Dispensed Cosmeceuticals Market is presumed to reach the market size of nearly USD 23.33 Billion by 2032 from USD 11.33 Billion in 2023 with a CAGR of 8.35% under the study period 2024-2032.

Physician dispensed cosmeceuticals refer to the various cosmetic products recommended by physicals that are specially compounded to offer heightened results with or without other treatments, such as surgery or Botox. These products differ from the OTC counterparts in the way they are formulated and their quality and strength. Physician-grade cosmeceuticals contain more substantial concentrations of peptides and Vitamin C. The concentration and delivery of peptides have a more significant impact on the appearance of the skin by encouraging better fibroblast activity or collagen synthesis. With the knowledgeable guidance of a licensed skincare professional, they offer far more versatility to match a patient's skin, condition, and lifestyle. They come in various strengths, formulations, and concentrations to fit all different skin types and requirements.

MARKET DYNAMICS

The significant growth in the demand for skincare and patients beginning to rely on dermatologists and cosmetic physicians to recommend suitable products for their skin, hair, and nails will be the main trending factors for physician-dispensed cosmeceuticals. The rising levels of stress and pollution causing increased damage to the skin, hair, and eyes among the urban population will benefit market growth. Research and development of newer and advanced cosmeceuticals to target several medical conditions will further propel market growth. Various cosmetic startups specializing in the manufacture and marketing of cosmeceuticals, as advised by dermatologists, will positively impact the market. The emergence of the novel concept of herbal medicine will boost the demand for organic physician dispensed cosmeceuticals. High-quality standards set by market leaders and stringent government regulations are few hindrances to the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Physician Dispensed Cosmeceuticals. The growth and trends of Physician Dispensed Cosmeceuticals industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Physician Dispensed Cosmeceuticals market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Face-care
  • Skincare

By Indication

  • Skin Lightening or De-pigmenting
  • Rhytide Reduction
  • Anti-Wrinkle/Aging
  • Scar-reducing
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Physician Dispensed Cosmeceuticals market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Physician Dispensed Cosmeceuticals market include AbbVie Inc. (Allergan), L'Oreal S.A., Jan Marini Skin Research Inc., Athena Cosmetics Inc., ZO Skin Health Inc., Galderma Laboratories, L.P., Procter & Gamble Co., The EsteE Lauder Companies Inc., Merz Pharma, Obagi Cosmeceuticals LLC, IS CLINICAL, Neutrogena, Velius LLC, Sonoma Pharmaceuticals Inc., Sientra Inc., Dynamic Techno Medicals, Implantech Associates Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. PHYSICIAN DISPENSED COSMECEUTICALS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Indication
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1. Overview By Product Type
  • 5.2. Historical and Forecast Data Analysis By Product Type
  • 5.3. Face-care Historic and Forecast Sales By Regions
  • 5.4. Skincare Historic and Forecast Sales By Regions

6. GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET ANALYSIS BY INDICATION

  • 6.1. Overview By Indication
  • 6.2. Historical and Forecast Data Analysis By Indication
  • 6.3. Skin Lightening or De-pigmenting Historic and Forecast Sales By Regions
  • 6.4. Rhytide Reduction Historic and Forecast Sales By Regions
  • 6.5. Anti-Wrinkle/Aging Historic and Forecast Sales By Regions
  • 6.6. Scar-reducing Historic and Forecast Sales By Regions
  • 6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE PHYSICIAN DISPENSED COSMECEUTICALS COMPANIES

  • 8.1. Physician Dispensed Cosmeceuticals Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF PHYSICIAN DISPENSED COSMECEUTICALS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. AbbVie Inc. (Allergan)
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. L'Oreal S.A.
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. Jan Marini Skin Research Inc.
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Athena Cosmetics Inc.
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. ZO Skin Health Inc.
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. Galderma Laboratories
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. L.P.
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Procter & Gamble Co.
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. The EsteE Lauder Companies Inc.
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. Merz Pharma
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments
  • 9.13. Obagi Cosmeceuticals LLC
    • 9.13.1 Company Overview
    • 9.13.2 Company Revenue
    • 9.13.3 Products
    • 9.13.4 Recent Developments
  • 9.14. IS CLINICAL
    • 9.14.1 Company Overview
    • 9.14.2 Company Revenue
    • 9.14.3 Products
    • 9.14.4 Recent Developments
  • 9.15. Neutrogena
    • 9.15.1 Company Overview
    • 9.15.2 Company Revenue
    • 9.15.3 Products
    • 9.15.4 Recent Developments
  • 9.16. Velius LLC
    • 9.16.1 Company Overview
    • 9.16.2 Company Revenue
    • 9.16.3 Products
    • 9.16.4 Recent Developments
  • 9.17. Sonoma Pharmaceuticals Inc.
    • 9.17.1 Company Overview
    • 9.17.2 Company Revenue
    • 9.17.3 Products
    • 9.17.4 Recent Developments
  • 9.18. Sientra Inc.
    • 9.18.1 Company Overview
    • 9.18.2 Company Revenue
    • 9.18.3 Products
    • 9.18.4 Recent Developments
  • 9.19. Dynamic Techno Medicals
    • 9.19.1 Company Overview
    • 9.19.2 Company Revenue
    • 9.19.3 Products
    • 9.19.4 Recent Developments
  • 9.20. Implantech Associates Inc
    • 9.20.1 Company Overview
    • 9.20.2 Company Revenue
    • 9.20.3 Products
    • 9.20.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies